These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 4734016)

  • 1. Selective depletion of dopamine following O-methylation of 6-hydroxydopamine.
    Ho BT; Meyer AL; Taylor D
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):47-56. PubMed ID: 4734016
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement by 6-hydroxydopamine of the effects of DOPA upon the motor activity of rats.
    Schoenfeld RI; Uretsky NJ
    J Pharmacol Exp Ther; 1973 Sep; 186(3):616-24. PubMed ID: 4728340
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of L-DOPA on S-adenosylmethionine levels and norepinephrine metabolism in rat brain.
    Wurtman RJ
    Adv Biochem Psychopharmacol; 1972; 6():241-6. PubMed ID: 5055596
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation between central catecholamine level and post-decapitation convulsion in rats treated with 6-hydroxydopamine.
    Suenaga N; Yamada K; Fukuda T
    Brain Res; 1977 Feb; 122(1):165-9. PubMed ID: 837220
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
    Cooper BR; Breese GR
    Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of 6-hydroxydopamine on hypothalamic norepinephrine and dopamine content, ultrastructure of the median eminence, and plasma corticosterone.
    Cuello AC; Shoemaker WJ; Ganong WF
    Brain Res; 1974 Sep; 78(1):57-69. PubMed ID: 4376442
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of carbaryl on catecholamines in brain regions.
    Ray SK; Haque SJ; Poddar MK
    Indian J Exp Biol; 1984 Mar; 22(3):141-4. PubMed ID: 6440860
    [No Abstract]   [Full Text] [Related]  

  • 9. Ingestive behavior following damage to central dopamine neurons: implications for homeostasis and recovery of function.
    Zigmond MJ; Stricker EM
    Adv Biochem Psychopharmacol; 1974; 12(0):385-402. PubMed ID: 4609140
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of cholecystokinin antiserum on the brain monoamine content in rats.
    Fekete M; Kádár T; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 57(2):177-83. PubMed ID: 7315376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of in vivo dopamine- -hydroxylase activity in rat brain.
    Stolk JM
    J Pharmacol Exp Ther; 1973 Aug; 186(2):230-40. PubMed ID: 4719778
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of catechol-O-methyl transferase inhibitors on behavior and dopamine metabolism.
    McKenzie GM
    Adv Biochem Psychopharmacol; 1974; 12(0):339-51. PubMed ID: 4419524
    [No Abstract]   [Full Text] [Related]  

  • 13. Catecholamine metabolism in the brain by membrane-bound and soluble catechol-o-methyltransferase (COMT) estimated by enzyme kinetic values.
    Reenilä I; Männistö PT
    Med Hypotheses; 2001 Nov; 57(5):628-32. PubMed ID: 11735324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of intraperitoneal injection of 6-hydroxydopamine on the turnover and the levels of the brain catecholamines and the levels of plasma corticosterone in rats.
    Kawa A; Kamisaki T; Ariyama T; Kawabata T; Maeda Y; Okamoto O; Kanehisa T
    Clin Exp Pharmacol Physiol; 1979; 6(2):123-8. PubMed ID: 421367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 2-and/or 5-methylated analogues of 6-hydroxydopamine on norepinephrine-and dopamine-containing neurons.
    Liang YO; Adams RN
    Mol Pharmacol; 1977 Sep; 13(5):805-18. PubMed ID: 895717
    [No Abstract]   [Full Text] [Related]  

  • 16. Altered effects of desipramine on operant performance after 6-hydroxydopamine-induced depletion of brain dopamine or norepinephrine.
    O'Donnell JM; Seiden LS
    J Pharmacol Exp Ther; 1984 Jun; 229(3):629-35. PubMed ID: 6427446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between catechol-O-methyltransferase and phenolsulfotransferase in the metabolism of dopamine in the rat brain.
    Buu NT
    J Neurochem; 1985 Nov; 45(5):1612-9. PubMed ID: 3930664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Learning impairment in rats after 6-hydroxydopamine-induced depletion of brain catecholamines.
    Mason ST; Iverson SD
    Nature; 1974 Apr; 248(5450):697-8. PubMed ID: 4151498
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of morphine and pentazocine on the turnover of noradrenaline and dopamine in various regions of the rat brain.
    Sugrue MF
    Br J Pharmacol; 1973 Mar; 47(3):644P. PubMed ID: 4730858
    [No Abstract]   [Full Text] [Related]  

  • 20. Mesocortical dopamine neurons: rapid transmitter turnover compared to other brain catecholamine systems.
    Bannon MJ; Bunney EB; Roth RH
    Brain Res; 1981 Aug; 218(1-2):376-82. PubMed ID: 7272743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.